Updated

Updated · PR Newswire · Jun 8

Mass Spectrometry Market to Hit $10.78 Billion by 2031 as Software Growth Tops 9.6%

Updated

Updated · PR Newswire · Jun 8

Mass Spectrometry Market to Hit $10.78 Billion by 2031 as Software Growth Tops 9.6%

1 articles · Updated · PR Newswire · Jun 8

$10.78 billion is the projected size of the mass spectrometry market in 2031, up from $7.07 billion in 2026, according to a MarketsandMarkets forecast.
6.4% to 8.8% annual growth is tied to higher pharmaceutical spending, expanding clinical research and stronger demand for precise quality control in drug manufacturing, food safety and life sciences.
LC-MS led the market with a 57.5% share in 2025, while pharmaceutical companies accounted for 24% of end-user demand as labs and hospitals expanded advanced testing capacity.
9.6% is the fastest projected growth rate among product segments for software and services, reflecting wider adoption of automation-enabled workflows, AI-assisted analysis and outsourced bioanalytical testing.

Sources

Center100%

Will the high cost of advanced analysis create a new divide in global healthcare and research?

As AI accelerates diagnostics, can regulatory approval keep pace with the speed of technological innovation?

With hospitals insourcing tests, are contract research organizations facing a threat or a new partnership opportunity?

1 total

Center100%